Antibodies to influenza virus A/H1N1 hemagglutinin in type 1 diabetes children diagnosed before, during and after the Swedish A(H1N1)pdm09 vaccination campaign 2009-2010.

Svensson, Matilda1; Ramelius, Anita; Nilsson, Anna-Lena; Delli, Ahmed; Larsson, Helena; Carlsson, Annelie; Forsander, Gun; Ivarsson, Sten; Ludvigsson, Johnny; Kockum, Ingrid; Marcus, Claude; Samuelsson, Ulf; Ortqvist, Eva; Lernmark, Åke

Antibodies to influenza virus A/H1N1 hemagglutinin in type 1 diabetes children diagnosed before, during and after the Swedish A(H1N1)pdm09 vaccination campaign 2009-2010.

Mark

Svensson, Matilda1 ^LU ; Ramelius, Anita ^LU ; Nilsson, Anna-Lena ^LU ; Delli, Ahmed ^LU ; Larsson, Helena ^LU ; Carlsson, Annelie ^LU

; Forsander, Gun ; Ivarsson, Sten ^LU ; Ludvigsson, Johnny and Kockum, Ingrid , et al. (2014) In Scandinavian Journal of Immunology 79(2). p.137-148

Abstract: We determined A/H1N1-HA antibodies in relation to HLA-DQ genotypes and islet autoantibodies at clinical diagnosis in 1141 incident 0.7-18 years old type 1 diabetes patients diagnosed April 2009 - December 2010. Antibodies to (35) S-methionine-labeled A/H1N1 hemagglutinin were determined in a radiobinding assay in patients diagnosed before (n=325), during (n=355) and after (n=461) the October 2009 - March 2010 Swedish A(H1N1)pdm09 vaccination campaign, along with HLA-DQ genotypes and autoantibodies against GAD, insulin, IA-2 and ZnT8 transporter. Before vaccination, 0.6% patients had A/H1N1-HA antibodies compared to 40% during and 27% after vaccination (p<0.0001). In children <3 years of age, A/H1N1-HA antibodies were found only... (More); We determined A/H1N1-HA antibodies in relation to HLA-DQ genotypes and islet autoantibodies at clinical diagnosis in 1141 incident 0.7-18 years old type 1 diabetes patients diagnosed April 2009 - December 2010. Antibodies to (35) S-methionine-labeled A/H1N1 hemagglutinin were determined in a radiobinding assay in patients diagnosed before (n=325), during (n=355) and after (n=461) the October 2009 - March 2010 Swedish A(H1N1)pdm09 vaccination campaign, along with HLA-DQ genotypes and autoantibodies against GAD, insulin, IA-2 and ZnT8 transporter. Before vaccination, 0.6% patients had A/H1N1-HA antibodies compared to 40% during and 27% after vaccination (p<0.0001). In children <3 years of age, A/H1N1-HA antibodies were found only during vaccination. The frequency of A/H1N1-HA antibodies during vaccination decreased after vaccination among the 3<6 (p=0.006) and 13<18 (p=0.001) but not among the 6<13 year olds. HLA-DQ2/8 positive children <3 years decreased from 54% (15/28) before and 68% (19/28) during, to 30% (9/30) after vaccination (p=0.014). Regardless of age, DQ2/2; 2/X (n=177) patients had lower frequency (p=0.020) and levels (p=0.042) of A/H1N1-HA antibodies compared to non-DQ2/2; 2/X (n=964) patients. GADA frequency was 50% before, 60% during and 51% after vaccination (p=0.009). ZnT8QA frequency increased from 30% before to 34% during and 41% after vaccination (p=0.002). Our findings suggest that young (<3 years) along with DQ2/2; 2/X patients were low responders to Pandemrix(®) . As the proportion of DQ2/8 patients <3 years of age decreased after vaccination and the frequencies of GADA and ZnT8QA were enhanced, it cannot be excluded that the vaccine affected clinical onset of type 1 diabetes. This article is protected by copyright. All rights reserved. (Less)

Please use this url to cite or link to this publication: https://lup.lub.lu.se/record/4225079

author

Svensson, Matilda1 ^LU ; Ramelius, Anita ^LU ; Nilsson, Anna-Lena ^LU ; Delli, Ahmed ^LU ; Larsson, Helena ^LU ; Carlsson, Annelie ^LU

; Forsander, Gun ; Ivarsson, Sten ^LU ; Ludvigsson, Johnny and Kockum, Ingrid , et al. (More)

Svensson, Matilda1 ^LU ; Ramelius, Anita ^LU ; Nilsson, Anna-Lena ^LU ; Delli, Ahmed ^LU ; Larsson, Helena ^LU ; Carlsson, Annelie ^LU

; Forsander, Gun ; Ivarsson, Sten ^LU ; Ludvigsson, Johnny ; Kockum, Ingrid ; Marcus, Claude ; Samuelsson, Ulf ; Ortqvist, Eva and Lernmark, Åke ^LU

(Less)

organization

publishing date

2014

type

Contribution to journal

publication status

published

subject

Immunology in the medical area

in

Scandinavian Journal of Immunology

volume

79

issue

2

pages

137 - 148

publisher

Wiley-Blackwell

external identifiers

pmid:24313339
wos:000336525900009
scopus:84897018161
pmid:24313339

ISSN

1365-3083

DOI

10.1111/sji.12138

project

Better Diabetes Diagnosis (BDD)

language

English

LU publication?

yes

id

b9b8d3bd-ac9e-4896-8e84-79f343085b72 (old id 4225079)

alternative location

http://www.ncbi.nlm.nih.gov/pubmed/24313339?dopt=Abstract

date added to LUP

2016-04-01 09:52:37

date last changed

2023-01-01 22:53:36

@article{b9b8d3bd-ac9e-4896-8e84-79f343085b72,
  abstract     = {{We determined A/H1N1-HA antibodies in relation to HLA-DQ genotypes and islet autoantibodies at clinical diagnosis in 1141 incident 0.7-18 years old type 1 diabetes patients diagnosed April 2009 - December 2010. Antibodies to (35) S-methionine-labeled A/H1N1 hemagglutinin were determined in a radiobinding assay in patients diagnosed before (n=325), during (n=355) and after (n=461) the October 2009 - March 2010 Swedish A(H1N1)pdm09 vaccination campaign, along with HLA-DQ genotypes and autoantibodies against GAD, insulin, IA-2 and ZnT8 transporter. Before vaccination, 0.6% patients had A/H1N1-HA antibodies compared to 40% during and 27% after vaccination (p&lt;0.0001). In children &lt;3 years of age, A/H1N1-HA antibodies were found only during vaccination. The frequency of A/H1N1-HA antibodies during vaccination decreased after vaccination among the 3&lt;6 (p=0.006) and 13&lt;18 (p=0.001) but not among the 6&lt;13 year olds. HLA-DQ2/8 positive children &lt;3 years decreased from 54% (15/28) before and 68% (19/28) during, to 30% (9/30) after vaccination (p=0.014). Regardless of age, DQ2/2; 2/X (n=177) patients had lower frequency (p=0.020) and levels (p=0.042) of A/H1N1-HA antibodies compared to non-DQ2/2; 2/X (n=964) patients. GADA frequency was 50% before, 60% during and 51% after vaccination (p=0.009). ZnT8QA frequency increased from 30% before to 34% during and 41% after vaccination (p=0.002). Our findings suggest that young (&lt;3 years) along with DQ2/2; 2/X patients were low responders to Pandemrix(®) . As the proportion of DQ2/8 patients &lt;3 years of age decreased after vaccination and the frequencies of GADA and ZnT8QA were enhanced, it cannot be excluded that the vaccine affected clinical onset of type 1 diabetes. This article is protected by copyright. All rights reserved.}},
  author       = {{Svensson, Matilda1 and Ramelius, Anita and Nilsson, Anna-Lena and Delli, Ahmed and Larsson, Helena and Carlsson, Annelie and Forsander, Gun and Ivarsson, Sten and Ludvigsson, Johnny and Kockum, Ingrid and Marcus, Claude and Samuelsson, Ulf and Ortqvist, Eva and Lernmark, Åke}},
  issn         = {{1365-3083}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{137--148}},
  publisher    = {{Wiley-Blackwell}},
  series       = {{Scandinavian Journal of Immunology}},
  title        = {{Antibodies to influenza virus A/H1N1 hemagglutinin in type 1 diabetes children diagnosed before, during and after the Swedish A(H1N1)pdm09 vaccination campaign 2009-2010.}},
  url          = {{http://dx.doi.org/10.1111/sji.12138}},
  doi          = {{10.1111/sji.12138}},
  volume       = {{79}},
  year         = {{2014}},
}

Lund University Publications

LUND UNIVERSITY LIBRARIES

Antibodies to influenza virus A/H1N1 hemagglutinin in type 1 diabetes children diagnosed before, during and after the Swedish A(H1N1)pdm09 vaccination campaign 2009-2010.